Results 221 to 230 of about 31,066,857 (388)

B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements. [PDF]

open access: yesBlood Cancer Discov
Varano G   +69 more
europepmc   +1 more source

Development of B Cell Subsets: Effect of Priming on in Vitro TNP-LPS Responsiveness [PDF]

open access: bronze, 1978
Fernando Dı́az-Espada   +2 more
openalex   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

open access: yesMolecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani   +14 more
wiley   +1 more source

B-Cell Lymphoma Presenting as a Pancreatic Mass. [PDF]

open access: yesJ Med Cases
Badran S   +4 more
europepmc   +1 more source

Factors influencing adherence of group B streptococci to human vaginal epithelial cells [PDF]

open access: bronze, 1979
Sam M. Zawaneh   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy